Department of Oriental Physiology, Kyung Hee East-West Pharmaceutical Research Institute, College of Pharmacy, Kyung Hee University, #1 Hoegi-dong, Dongdaemun-gu, Seoul 130-701, Republic of Korea.
J Ethnopharmacol. 2010 Mar 2;128(1):241-7. doi: 10.1016/j.jep.2010.01.023. Epub 2010 Jan 14.
Bambusae Caulis in Taeniam (BC) was known as traditional herbal medicine with anti-inflammatory property in the Orient.
Allergic asthma is inflammatory disease of airways associated with enhanced T helper (Th) 2 lymphocytes responses to allergens, leading to eosinophilic infiltration and elevated serum IgE levels. Although there were some studies that BC extract had an anti-inflammatory property, there was no study on asthma. In present study, we investigated the suitability of BC extract as a therapeutic candidate in the treatment of allergic airway disease in ovalbumin-induced asthma model.
Balb/C mice (female, 6 weeks old) were treated by ovalbumin sensitization and nebulization, and used as asthma model. The number of eosinophil in bronchoalveolar lavage (BAL) fluid and the degree of eosinophila were investigated by hematoxylin and eosin stain and the infiltration of inflammatory cells into lung tissues was examined by staining by hematoxylin and eosin solution. The levels of interleukin (IL)-4 in BAL fluid, immunoglobulin E (IgE) in serum, interferon (IFN)-gamma and IL-4 production in splenocyte culture from Balb/C mice (not treated, 6 weeks old) that incubated with or without BC extract for 48 h were determined by enzyme-linked immunosorbent assay.
The level of eosinophils was decreased by treatment of the animals with BC extract (40 mg/kg) and correspondingly, a significantly lowered degree of eosinophila was also reported (p<0.01). In lung tissue, BC extract reduced the increased immune cell infiltration induced by OVA (p<0.05). Furthermore, the levels of IL-4 and IgE in BAL fluid or serum up-regulated by OVA was decreased by BC extract. Finally, IFN-gamma production was significantly increased (p<0.01), while IL-4 production significantly decreased (p<0.01), after treatment of the culture supernatants of splenocytes with BC extract.
These results indicated that BC extract reduces OVA-induced airway inflammation and Th 2 response in mice, suggesting that BC extract can be a therapeutic candidate for allergic airway disease, including asthma.
在东方,Bambusae Caulis in Taeniam(BC)被认为是一种具有抗炎特性的传统草药。
过敏性哮喘是一种气道炎症性疾病,与对过敏原的辅助性 T 细胞(Th)2 淋巴细胞反应增强有关,导致嗜酸性粒细胞浸润和血清 IgE 水平升高。虽然有一些研究表明 BC 提取物具有抗炎特性,但没有关于哮喘的研究。在本研究中,我们研究了 BC 提取物作为一种治疗候选药物,在卵清蛋白诱导的哮喘模型中治疗过敏性气道疾病的适宜性。
Balb/C 小鼠(雌性,6 周龄)经卵清蛋白致敏和雾化处理,作为哮喘模型。通过苏木精和伊红染色观察支气管肺泡灌洗液(BAL)中嗜酸性粒细胞的数量和嗜酸性粒细胞的程度,并通过苏木精和伊红溶液染色观察炎性细胞浸润到肺组织的程度。通过酶联免疫吸附试验测定 Balb/C 小鼠(未经处理,6 周龄)BAL 液中白细胞介素(IL)-4、血清免疫球蛋白 E(IgE)、干扰素(IFN)-γ和脾细胞培养物中 IL-4 的产生,脾细胞在有无 BC 提取物孵育 48 小时。
用 BC 提取物(40mg/kg)处理动物可降低嗜酸性粒细胞水平,相应地,嗜酸性粒细胞程度也显著降低(p<0.01)。在肺组织中,BC 提取物减少了 OVA 诱导的免疫细胞浸润增加(p<0.05)。此外,BC 提取物可降低由 OVA 上调的 BAL 液或血清中 IL-4 和 IgE 的水平。最后,用 BC 提取物处理脾细胞培养上清液后,IFN-γ的产生显著增加(p<0.01),而 IL-4 的产生显著降低(p<0.01)。
这些结果表明,BC 提取物可降低 OVA 诱导的气道炎症和小鼠 Th2 反应,提示 BC 提取物可作为过敏性气道疾病的治疗候选药物,包括哮喘。